Stockreport

Truist Lifts Immunovant (IMVT) PT to $22 on Updated 2026 Financial Modeling [Yahoo! Finance]

Immunovant, Inc.  (IMVT) 
PDF price target on Immunovant to $22 from $16, while maintaining a Hold rating on the shares. While the firm updated its financial model, Truist informed investors that its [Read more]